Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Valuation Expected To Reach $11.53 Billion By 2029, Growing At A Rate Of 16.7%
Discover trends, market shifts, and competitive outlooks for the advanced therapy medicinal products contract development and manufacturing organization (cdmo) industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#How Fast Is The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Expected to Grow Between 2025 And 2029?#_x000D_
In recent years, the market size of contract development and manufacturing organizations (CDMO) for advanced therapy medicinal products has seen substantial growth. It is projected to increase from $5.31 billion in 2024 to $6.22 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 17.0%. This growth during the historic period can be credited to factors such as an increase in ATMP clinical trials, growing recognition and confidence among researchers about the advantages of advanced therapy, the existence of numerous ATMP CDMOs, escalating efforts to create new therapies for diverse diseases, and government initiatives that encourage these developments._x000D_
_x000D_
The market size for advanced therapy medicinal products contract development and manufacturing organization (CDMO) is projected to expand rapidly in the coming years. It’s predicted to reach $11.53 billion by 2029 with a compound annual growth rate (CAGR) of 16.7%. This growth over the forecast period is due to considerable investment by CDMOs, an increase in new cell and gene therapy (CGT) sector players, a rise in grants and investments for cell and gene therapy development, higher pharmaceutical R&D expenditure and an increase in clinical trials for ATMPs. During the forecast period, some notable trends are anticipated, such as progress in AAV biomanufacturing facilities, enlargement of cell and gene therapy manufacturing, technological advancements in cell and gene therapy, a growing demand for access to advanced platforms and technologies, along with the inclusion of advanced technologies like CRISPR and next-generation sequencing for more precise results._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=15719&type=smp_x000D_
_x000D_
#Which Factors and External Forces Are Driving Demand in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?#_x000D_
The anticipated growth in the advanced therapy medicinal products CDMO market is likely to be driven by an uptick in clinical trials. Clinical trials, which are research studies conducted with human participants to ascertain the safety and effectiveness of medical interventions, are on the rise. The uptick is due to an increased demand for innovative treatments and the need to manage a growing global disease burden. The use of advanced therapy medicinal products is increasing the demand for CDMO manufacturing services, resulting in the need for specialized skill sets and infrastructure. The data collected from clinical trials assists in refining manufacturing processes, ensuring scalability, and maintaining quality to satisfy extensive clinical and commercial needs. For instance, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade group, reported that the annual initiation of industry clinical trials in the UK had increased slightly by 4.3%, from 394 in 2021 to 411 in 2022. Thus, the surge in clinical trials numbers is contributing to the growth of the advanced therapy medicinal products CDMO market._x000D_
_x000D_
#Which Segments in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Offer the Most Growth?#_x000D_
The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market covered in this report is segmented –_x000D_
_x000D_
1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered_x000D_
2) By Phase: Phase I, Phase II, Phase III, Phase IV_x000D_
3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology_x000D_
_x000D_
Subsegments:_x000D_
1) By Gene Therapy: Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products_x000D_
2) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy_x000D_
3) By Tissue Engineered: Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=15719&type=smp_x000D_
_x000D_
#What Are the Fastest-Growing Geographies in the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?#_x000D_
North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_
_x000D_
#Which Cutting-Edge Market Trends Are Expected to Drive the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market’s Growth?#_x000D_
Leading businesses in the advanced therapy medicinal products CDMO market are innovating their cell therapy manufacturing services to address key challenges in this field and expedite their partners’ development projects. These services, offered by contract development and manufacturing organizations, range from the early stages of preclinical development to the later stages of clinical trials and commercial marketing. For example, Pluristem Therapeutics Inc., a biotech firm based in Israel that converts cells into solutions, unveiled PluriCDMO in January 2024. This new business division provides cell therapy manufacturing, using a patented bioreactor system that makes 3D cell multiplication feasible and aids in producing diverse cell types including stem cells, induced pluripotent stem cells, exosomes, and immune therapies. PluriCDMO aims to offer patients vital, high-quality medicines while assuring reliable batch-to-batch consistency in a scalable, cost-efficient, and compliant way in good manufacturing practice environments._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#What Are the Key Elements That Define the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?#_x000D_
An advanced therapy medicinal product contract development and manufacturing organization (CDMO) is a specialized service provider that assists in the development and manufacturing of advanced therapy medicinal products. The objective of an advanced therapy medicinal product CDMO is to provide the expertise, infrastructure, and resources required for advanced therapy medicinal product development and manufacturing._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15719_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 3156230293_x000D_
Asia +44 2071930708_x000D_
Europe +44 2071930708_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
